Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns
- Cancer risk warning for tacrolimus ointment. // Reactions Weekly;6/9/2012, Issue 1405, p4
The article reports on a "Dear Healthcare Professional" letter issued by Astella Pharma Europe concerns the risk of cancers in patients treated with tacrolimus and ointment for atopic dermatitis.
- New study focuses on treatment, resources, and impact of atopic dermatitis. Groves, Nancy // Dermatology Times;Mar2004, Vol. 25 Issue 3, p34
Reports on the efficacy of tacrolimus, a calcineurin inhibitor, in the treatment of atopic dermatitis. Impact of the drug on disease severity and in scores on the Body Surface Area (BSA) and Eczema Area Severity Index (EASI); Effect on healthcare utilization and expenditure; Importance of...
- Tacrolimus. // Reactions Weekly;1/21/2006, Issue 1085, p25
The article presents a case report involving a girl who developed food allergy to egg proteins and dory fish following widespread topical application of tacrolimus for atopic dermatitis. It relates the irregularities that developed after starting treatment with tacrolimus.
- Safe alternative to steroids treats facial, eyelid atopic dermatitis. Kuznar, Wayne // Dermatology Times;Aug2001, Vol. 22 Issue 8, p14
Discusses the use of tacrolimus (Protopic) ointment as a safe alternative to steroids in the treatment of atopic dermatitis on the face and eyelids. Safety and effectiveness of 0.03% and 0.1% tacrolimus ointment in adults and children; Percentage of patients who showed improvement in erythema,...
- Tacrolimus could prove useful for treating atopic dermatitis. Guttman, Cheryl // Dermatology Times;Aug97, Vol. 18 Issue 8, p9
Reports that topical tacrolimus (FK-506) is an effective treatment for atopic dermatitis. Improvements observed on the patients after treatment; Most common patient complaint about the treatment; How the cellular mode of action of tacrolimus was investigated.
- Shorter-term Treatment. Guttman, Cheryl // Dermatology Times;Apr2003, Vol. 24 Issue 4, p62
Focuses on the use of tacrolimus ointment in treating moderate to severe atopic dermatitis in children in Winston-Salem, North Carolina. Reduction of severity and pruritus in atopic dermatitis; Elimination of the need for corticosteroids; Factors to consider prior to drug administration.
- Skin normalized with long-term tacrolimus therapy. Magee, Jim // Dermatology Times;Feb2001, Vol. 22 Issue 2, p17
Focuses on data presented during the ninth congress of the European Academy of Dermatology and Venerealogy by Finnish investigator Sakari Reitamo which indicates that restoration of the TH1/TH2 balance and skin normalization were among the benefits of long-term topical tacrolimus patients with...
- Topical tacrolimus ointment challenges steroids. Magee, Jim // Dermatology Times;Feb2001, Vol. 22 Issue 2, p17
Reports that data from studies conducted in the United States and Europe indicates that topical tacrolimus ointment (Protopic) is safe and effective for the treatment of atopic dermatitis (AD). Related presentations made during the ninth annual congress of the European Academy of Dermatology...
- Highly Researched Topical Tacrolimus Offers Promise vs. Atopic Dermatitis. Guttman, Cheryl // Dermatology Times;May99, Vol. 20 Issue 5, p1
Reports on the potential of the topical drug tacrolimus as treatment for atopic dermatitis in the United States. Significant improvement of manifestations of atopic dermatitis; Side effects and toxicity; Other treatment strategies.